Showing results (71-80 of 619) with videos related to
Sort By:
Pageof 62
Expert Review of Cardiovascular Therapy|March 28, 2025
Antithrombotic therapy after left atrial appendage occlusionCarmelo Raffo, Antonio Greco, Davide CapodannoCirculation. Cardiovascular Interventions|November 1, 2023
Navigating the Course of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Review of Guided ApproachesNicola Ammirabile, Davide Landolina, Davide CapodannoNature Reviews. Cardiology|August 5, 2016
Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular diseaseDavide Capodanno, Mark Alberts, Dominick J AngiolilloTherapeutic Advances in Cardiovascular Disease|December 10, 2019
Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stentingSergio Buccheri, Dominick J Angiolillo, Davide CapodannoExpert Opinion on Drug Safety|December 4, 2023
Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and managementClaudio Laudani, Davide Capodanno, Dominick Joseph AngiolilloEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Early discontinuation of acetylsalicylic acid after angioplasty in acute coronary syndromes: the NEO-MINDSET and TARGET-FIRST studiesGiacinto Di Leo, Diego Nastasi, Davide CapodannoExpert Review of Cardiovascular Therapy|July 15, 2020
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitusDario Calderone, Davide Capodanno, Dominick J AngiolilloExpert Opinion on Pharmacotherapy|July 24, 2024
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic strokeClaudio Laudani, Davide Capodanno, Dominick J AngiolilloExpert Opinion on Drug Metabolism & Toxicology|October 18, 2023
Evaluating the pharmacokinetic and pharmacodynamic impact of different modes of ticagrelor administrationMarco Spagnolo, Dominick J Angiolillo, Davide CapodannoExpert Review of Cardiovascular Therapy|February 9, 2010
Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonistDavide Capodanno, Kodlipet Dharmashankar, Dominick J AngiolilloPageof 62